Target intelligence / Profile preview

Bacterial Biofilm Disruption (N/A)

Target
N/A
Molecular classification
Other
01

Overview

Bacterial biofilm disruption is a therapeutic strategy that aims to break down the protective matrix of bacterial biofilms, rendering the embedded bacteria more susceptible to antibiotics and host immune defenses. It is particularly relevant in chronic respiratory infections associated with cystic fibrosis, where biofilms contribute to persistent inflammation and antimicrobial resistance. Approaches include degrading matrix components like exopolysaccharides, eDNA, and structural proteins such as DNABII, as well as interfering with quorum sensing and inhibiting matrix synthesis.

Other names
Biofilm EradicationBiofilm DegradationBiofilm InterferenceExtracellular matrix disruption
02

Mechanism of action

Disrupting the biofilm matrix to expose bacteria to antibiotics and immune cells.

03

Biological functions

Disruption of bacterial communitiesIncreased antibiotic sensitivityEnhanced immune clearancePathogen Dispersal
04

Disease associations

Cystic FibrosisChronic infectionsRespiratory infectionsCOPD exacerbations
05

Safety considerations

Potential for increased inflammation due to release of bacterial componentsNon-specific targeting of beneficial biofilmsDevelopment of resistance to biofilm disrupting agentsImmune response to biofilm degrading enzymes
06

Interacting drugs

HuTipMab

3 more in the full profile.

07

Biomarkers

Biofilm load in sputumDNABII protein levelseDNA levelsAlginate levelsAntibiotic susceptibility testing (post-disruption)

Beyond the preview

Go deeper on Bacterial Biofilm Disruption (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial Biofilm Disruption (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call